Recent Company News

• 12:52 PM ET Jun 24, 2025
  

  Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices

• 09:29 AM ET Jun 20, 2025
  

  Gene therapy reviewer at FDA's CBER escorted out on Wednesday

• 09:16 AM ET May 08, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:19 AM ET May 08, 2025
  

  StreetAccount Summary - US Pre-market trading

• 02:06 AM ET Jun 12, 2025
  

  Autolus Therapeutics presents updated long-term data from FELIX study of obe-cel ($2.24, 0.00)

• 09:02 AM ET May 23, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:25 AM ET May 23, 2025
  

  EMA CHMP publishes summary of opinions for May 2025 meeting

• 07:35 AM ET May 23, 2025
  

  EU's CHMP adopted a positive opinion recommending the granting of a conditional marketing authorisation for Autolus Therapeutics's Aucatzyl ($1.53, 0.00)